Differential distribution of the normal and mutated forms of huntingtin in the human brain - PubMed (original) (raw)
doi: 10.1002/ana.410420507.
G Cancel, Y Trottier, D Devys, L Tora, Y Lutz, G Imbert, F Saudou, G Stevanin, Y Agid, A Brice, J L Mandel, E C Hirsch
Affiliations
- PMID: 9392570
- DOI: 10.1002/ana.410420507
Differential distribution of the normal and mutated forms of huntingtin in the human brain
I Gourfinkel-An et al. Ann Neurol. 1997 Nov.
Abstract
Huntington's disease is an inherited disorder caused by expansion of a CAG trinucleotide repeat in the IT15 gene, which leads to expansion of a polyglutamine tract within the protein called huntingtin. Despite the characterization of the IT15 gene and the mutation involved in the disease, the normal function of huntingtin and the effects of the mutation on its function and on its neuronal location remain unknown. To study whether mutated huntingtin has the same neuronal distribution and intracellular location as normal huntingtin, we analyzed immunohistochemically both forms of this protein in the brain of 5 controls and 5 patients with Huntington's disease. We show that the distribution of mutated huntingtin is, like that of the normal form, heterogeneous throughout the brain, but is not limited to vulnerable neurons in Huntington's disease, supporting the hypothesis that the presence of the mutated huntingtin in a neuron is not in itself sufficient to lead to neuronal death. Moreover, whereas normal huntingtin is detected in some neuronal perikarya, nerve fibers, and nerve endings, the mutated form is observed in some neuronal perikarya and proximal nerve processes but is not detectable in nerve endings. Our results suggest that the expression or processing of the mutated huntingtin in perikarya and nerve endings differs quantitatively or qualitatively from the expression of the normal form in the same neuronal compartments.
Similar articles
- Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form.
Trottier Y, Devys D, Imbert G, Saudou F, An I, Lutz Y, Weber C, Agid Y, Hirsch EC, Mandel JL. Trottier Y, et al. Nat Genet. 1995 May;10(1):104-10. doi: 10.1038/ng0595-104. Nat Genet. 1995. PMID: 7647777 - Neuronal distribution of intranuclear inclusions in Huntington's disease with adult onset.
Gourfinkel-An I, Cancel G, Duyckaerts C, Faucheux B, Hauw JJ, Trottier Y, Brice A, Agid Y, Hirsch EC. Gourfinkel-An I, et al. Neuroreport. 1998 Jun 1;9(8):1823-6. doi: 10.1097/00001756-199806010-00028. Neuroreport. 1998. PMID: 9665608 - Huntingtin localization in brains of normal and Huntington's disease patients.
Sapp E, Schwarz C, Chase K, Bhide PG, Young AB, Penney J, Vonsattel JP, Aronin N, DiFiglia M. Sapp E, et al. Ann Neurol. 1997 Oct;42(4):604-12. doi: 10.1002/ana.410420411. Ann Neurol. 1997. PMID: 9382472 - Huntingtin-protein interactions and the pathogenesis of Huntington's disease.
Li SH, Li XJ. Li SH, et al. Trends Genet. 2004 Mar;20(3):146-54. doi: 10.1016/j.tig.2004.01.008. Trends Genet. 2004. PMID: 15036808 Review. - How does the Huntington's disease mutation damage cells?
Rubinsztein DC. Rubinsztein DC. Sci Aging Knowledge Environ. 2003 Sep 17;2003(37):PE26. doi: 10.1126/sageke.2003.37.pe26. Sci Aging Knowledge Environ. 2003. PMID: 13679594 Review.
Cited by
- Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease.
Fusco FR, Chen Q, Lamoreaux WJ, Figueredo-Cardenas G, Jiao Y, Coffman JA, Surmeier DJ, Honig MG, Carlock LR, Reiner A. Fusco FR, et al. J Neurosci. 1999 Feb 15;19(4):1189-202. doi: 10.1523/JNEUROSCI.19-04-01189.1999. J Neurosci. 1999. PMID: 9952397 Free PMC article. - Proteostasis in striatal cells and selective neurodegeneration in Huntington's disease.
Margulis J, Finkbeiner S. Margulis J, et al. Front Cell Neurosci. 2014 Aug 7;8:218. doi: 10.3389/fncel.2014.00218. eCollection 2014. Front Cell Neurosci. 2014. PMID: 25147502 Free PMC article. Review. - Modeling Huntington's disease in cells, flies, and mice.
Sipione S, Cattaneo E. Sipione S, et al. Mol Neurobiol. 2001 Feb;23(1):21-51. doi: 10.1385/MN:23:1:21. Mol Neurobiol. 2001. PMID: 11642542 - The Role of Adenosine Tone and Adenosine Receptors in Huntington's Disease.
Blum D, Chern Y, Domenici MR, Buée L, Lin CY, Rea W, Ferré S, Popoli P. Blum D, et al. J Caffeine Adenosine Res. 2018 Jun 1;8(2):43-58. doi: 10.1089/caff.2018.0006. J Caffeine Adenosine Res. 2018. PMID: 30023989 Free PMC article. Review. - FcepsilonRII/CD23 is expressed in Parkinson's disease and induces, in vitro, production of nitric oxide and tumor necrosis factor-alpha in glial cells.
Hunot S, Dugas N, Faucheux B, Hartmann A, Tardieu M, Debré P, Agid Y, Dugas B, Hirsch EC. Hunot S, et al. J Neurosci. 1999 May 1;19(9):3440-7. doi: 10.1523/JNEUROSCI.19-09-03440.1999. J Neurosci. 1999. PMID: 10212304 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical